Aurigene Pharma to invest USD 40 Mn in Telangana for biomanufacturing facility

Yet another big-ticket investment for Telangana in the life sciences sector. Aurigene Pharma will invest in Telangana for their state-of-the art biomanufacturing facility with investment of USD 40 Mn and employment to more than 250 people.

Further, the company envisions significant scaling-up of their investments in the future, which would result in a multi-fold increase in employment prospects in very advanced science and manufacturing technologies. Aurigene Pharma is a leading contract research, development, and manufacturing services organization and a step-down subsidiary of Dr. Reddys Laboratories.

The company representatives have met Minister KT Rama Rao in Hyderabad and the proposed plant would come up in the Genome Valley. Welcoming the decision Minister KT Rama Rao said, “Hyderabad offers an excellent ecosystem for biologics R&D and manufacturing with 30-40 percent of total capacity for biologics in India and I’m happy to note this investment has further bolstered Hyderabad’s status as the top choice for biopharmaceutical research and production.”

The Minister added that this investment aligns perfectly with the State government’s vision to enhance “Complex manufacturing at scale” wherein the objective is to make a giant leap towards advanced therapeutic modalities.